A carregar...

Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Background: Glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of hypoglycemic drugs, including exenatide, liraglutide, albiglutide, lixisenatide, and taspoglutide. Insulin glargine is a standard agent used to supplement basal insulin in type 2 diabetes mellitus (T2DM). Objective: The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Wei-Xin, Gou, Jian-Feng, Tian, Jin-Hui, Yan, Xiang, Yang, Lin
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3969618/
https://ncbi.nlm.nih.gov/pubmed/24688145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2010.08.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!